Experts Warn Against Faricimab Rechallenge Post-Inflammation
Faricimab should be readministered with caution in patients who develop mild intraocular inflammation with a previous dose of the biologic agent, researchers warned.
Medscape Medical News
source https://www.medscape.com/viewarticle/experts-warn-against-faricimab-rechallenge-post-inflammation-2025a100021x?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/experts-warn-against-faricimab-rechallenge-post-inflammation-2025a100021x?src=rss
Comments
Post a Comment